Eli Lilly

5 biopharmas to watch as the decade's last earnings kick off
5 biopharmas to watch as the decade's last earnings kick off
BioPharma Dive
earnings
Novartis
Biogen
Eli Lilly
Global Blood Therapeutics
Bluebird Bio
Flag link:
Eli Lilly reserves $470M for new manufacturing plant — and North Carolina is more than pleased
Eli Lilly reserves $470M for new manufacturing plant — and North Carolina is more than pleased
Endpoints
Eli Lilly
drug manufacturing
North Carolina
hirings
Flag link:
What Does the Future Hold for Nextcure?
What Does the Future Hold for Nextcure?
Motley Fool
NextCure
Eli Lilly
oncology
Flag link:
With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans
With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans
BioSpace
drug pricing
Roche
Eli Lilly
Amgen
Alnylam
Sanofi
Flag link:
Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Motley Fool
Eli Lilly
generics
insulin
diabetes
Lispro
Flag link:
Merck, Lilly and Amgen square off in appeals court over drug pricing in TV ads
Merck, Lilly and Amgen square off in appeals court over drug pricing in TV ads
Fierce Pharma
Merck
Eli Lilly
Amgen
HHS
drug pricing
television ads
Flag link:
Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion
Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion
BioSpace
Eli Lilly
Dermira
dermatology
M&A
atopic dermatitis
Flag link:
Lilly, Strateos open remote-controlled robotic research lab in San Diego
Lilly, Strateos open remote-controlled robotic research lab in San Diego
BioPharma Dive
Eli Lilly
Strateos
robotics
San Diego
Flag link:
A big finish confirms 2019 as a takeover year to remember
A big finish confirms 2019 as a takeover year to remember
EP Vantage
M&A
AbbVie
Allergan
Astellas
Bristol-Myers Squibb
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Flag link:
Lilly claims another victory in Alimta patent defence
Lilly claims another victory in Alimta patent defence
Pharmaforum
Eli Lilly
Alimta
patents
generics
Flag link:
Is there a future for pharma in neuro?
Is there a future for pharma in neuro?
Fierce Biotech
Neuroscience
R&D
Eli Lilly
Amgen
GSK
Novartis
Flag link:
After 'nonsense' retort, Lilly CEO urges patients to seek its help affording insulin
After 'nonsense' retort, Lilly CEO urges patients to seek its help affording insulin
Fierce Pharma
Eli Lilly
David Ricks
Pharma CEOs
insulin
patients
diabetes
Flag link:
Lilly launches real-world study to benchmark Emgality against migraine rivals
Lilly launches real-world study to benchmark Emgality against migraine rivals
Fierce Pharma
Eli Lilly
migraines
Emgality
real world evidence
RWE
Flag link:
Chuffed on new launches, Eli Lilly unveils Street-beating 2020 sales forecast
Chuffed on new launches, Eli Lilly unveils Street-beating 2020 sales forecast
Fierce Pharma
Eli Lilly
Flag link:
Lilly doubles down on Dexcom tech for connected insulin devices
Lilly doubles down on Dexcom tech for connected insulin devices
Pharmaforum
Eli Lilly
DexCom
continuous glucose monitoring
devices
diabetes
Flag link:
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint
Pharmaceutical Business Review
Jardiance
Eli Lilly
Boehringer Ingelheim
type 2 diabetes
chronic heart failure
clinical trials
Flag link:
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Eli Lilly, Boehringer's Jardiance flops heart failure trial, falling behind AZ's Farxiga
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
Farxiga
diabetes
AstraZeneca
heart failure
Flag link:
Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer
Upcoming events – Axsome’s depression data and Eli Lilly’s IL-10 in lung cancer
EP Vantage
Axsome Therapeutics
AXS-05
treatment-resistant depression
depression
Eli Lilly
pegilodecakin
lung cancer
Flag link:
Leukemia rivals try to stay ahead as Merck, Lilly chase
Leukemia rivals try to stay ahead as Merck, Lilly chase
Biopharma Dive
Merck
Eli Lilly
AbbVie
JNJ
Imbruvica
ARQ 531
LOXO-305
CLL
ASH2019
Flag link:
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
Fierce Biotech
Eli Lilly
Loxo Oncology
ASH2019
CLL
Flag link:

Pages